Skip to main content
. 2019 Nov 29;19:1161. doi: 10.1186/s12885-019-6373-y

Fig. 3.

Fig. 3

Forest plot of studies evaluating the hazard ratio of high C-reactive protein/albumin ratio for overall survival of esophageal cancer patients divided by the ratio of neoadjuvant chemotherapy